Bruce Strober
Impact in
- Dermatology top 0.02%
- Dermatology and Skin Diseases
- Hidradenitis Suppurativa and Treatments
- Immunology top 0.1%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Immunology 231
- Psoriasis: Treatment and Pathogenesis 222
- Dermatology 57
- Dermatology and Skin Diseases 40
- Co-authors
- Mark Lebwohl (94 shared papers)Kim Papp (48 shared papers)Alan Menter (17 shared papers)Kenneth B. Gordon (33 shared papers)Richard G. Langley (28 shared papers)Martin J. Blaser (3 shared papers)Alexa B. Kimball (13 shared papers)Yihua Gu (6 shared papers)
- Journals
- Journal of the American Academy of Dermatology (72 papers)British Journal of Dermatology (24 papers)Dermatology and Therapy (18 papers)Journal of the European Academy of Dermatology and Venereology (16 papers)Journal of Dermatological Treatment (12 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Bruce Strober
266 papers receiving 11.4k citations
Bruce Strober's Hit Papers
Peers
Comparison fields: 5 of 130
- Dermatology 3.6k
- Immunology 7.4k
- Rheumatology 1.6k
- Pathology and Forensic Medicine 1.3k
- Hematology 659
Countries citing papers authored by Bruce Strober
This map shows the geographic impact of Bruce Strober's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Strober with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Strober more than expected).
Fields of papers citing papers by Bruce Strober
This network shows the impact of papers produced by Bruce Strober. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Strober. The network helps show where Bruce Strober may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruce Strober, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 296 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial Hit paper breakdown → | 2007 | 711 |
| 2 | Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis Hit paper breakdown → | 2010 | 670 |
| 3 | The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest Hit paper breakdown → | 1994 | 550 |
| 4 | Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials Hit paper breakdown → | 2018 | 476 |
| 5 | 2008 | 367 | |
| 6 | 2008 | 355 | |
| 7 | Community differentiation of the cutaneous microbiota in psoriasis Hit paper breakdown → | 2013 | 330 |
| 8 | 2013 | 328 | |
| 9 | Hidradenitis suppurativa Hit paper breakdown → | 2019 | 291 |
| 10 | 2012 | 276 | |
| 11 | 2007 | 276 | |
| 12 | 2009 | 271 | |
| 13 | Bimekizumab versus Secukinumab in Plaque Psoriasis Hit paper breakdown → | 2021 | 250 |
| 14 | Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial Hit paper breakdown → | 2022 | 239 |
| 15 | 2011 | 225 | |
| 16 | 1996 | 218 | |
| 17 | 2006 | 209 | |
| 18 | Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial Hit paper breakdown → | 2022 | 192 |
| 19 | 2008 | 163 | |
| 20 | 2011 | 151 |
About Bruce Strober
Bruce Strober is a scholar working on Immunology, Dermatology, Pathology and Forensic Medicine, Rheumatology and Pediatrics, Perinatology and Child Health, having authored 296 papers that have together received 11.8k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (222 papers), Dermatology and Skin Diseases (40 papers), Pharmaceutical studies and practices (24 papers), Autoimmune Bullous Skin Diseases (23 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Asthma and respiratory diseases (11 papers) and Cytokine Signaling Pathways and Interactions (10 papers). The work is most often cited by research in Dermatology (3.6k citations), Immunology (7.4k citations), Rheumatology (1.6k citations), Pathology and Forensic Medicine (1.3k citations) and Hematology (659 citations). Bruce Strober has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Mark Lebwohl, Kim Papp, Alan Menter, Kenneth B. Gordon, Richard G. Langley, Martin J. Blaser, Alexa B. Kimball, Yihua Gu, Samantha R. Goldburg and Michael Payette. Their work appears in journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology, Dermatology and Therapy, Journal of the European Academy of Dermatology and Venereology and Journal of Dermatological Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.